Items where authors include "Kok, Ken"

Article

Thaler, Melissa, Ofman, Tim P., Kok, Ken et al. (16 more authors) (2024) Epi-cyclophellitol cyclosulfate, a mechanism-based ER α-glucosidase II inhibitor, blocks replication of SARS-CoV-2 and other coronaviruses. ACS Central Science. 1594–1608. ISSN 2374-7943 (In Press)

Ofman, Tim P., Heming, Jurriaan J. A., Nin-Hill, Alba et al. (15 more authors) (2024) Conformational and Electronic Variations in 1,2- and 1,6-Cyclophellitols and Their Impact on Retaining α-Glucosidase Inhibition. Chemistry - A European Journal. ISSN 1521-3765

Males, Alexandra orcid.org/0000-0002-7250-8300, Kok, Ken, Nin-Hill, Alba et al. (8 more authors) (2023) Cyclosulfamidate Mannose-Configured Cyclitol Allows Specific Allele-Dependent Inhibition of GH47 α-D-Mannosidases Through a Bump-Hole Strategy. Chemical Science. pp. 13581-13586. ISSN 2041-6539

Kok, Ken, Kuo, Chi Lin, Katzy, Rebecca E. et al. (10 more authors) (2022) 1,6- epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease. Journal of the American Chemical Society. 14819–14827. ISSN 1520-5126